Stockscreener 앱 받기
2.12
2.42%
0.05
시간 외 거래:
2.12
전일 마감가:
$2.07
열려 있는:
$2.07
하루 거래량:
1.16M
Relative Volume:
0.37
시가총액:
$289.36M
수익:
$288.95M
순이익/손실:
$-119.03M
주가수익비율:
-2.3542
EPS:
-0.9005
순현금흐름:
$60.67M
1주 성능:
+5.47%
1개월 성능:
+9.28%
6개월 성능:
-72.99%
1년 성능:
-76.37%
1일 변동 폭
$2.02
$2.20
1주일 범위
$1.96
$2.20
52주 변동 폭
$1.665
$11.55
마라바이 라이프 Stock (MRVI) Company Profile
명칭
Maravai Lifesciences Holdings Inc
전화
(858) 546-0004
주소
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
MRVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
2.12 | 289.36M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
마라바이 라이프 Stock (MRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Neutral |
| 2024-12-05 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-08 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | 개시 | Craig Hallum | Buy |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-08-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-01-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-11-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2020-12-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Stifel | Buy |
| 2020-12-15 | 개시 | William Blair | Outperform |
| 2020-12-14 | 개시 | UBS | Buy |
모두보기
마라바이 라이프 주식(MRVI)의 최신 뉴스
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Investors who lost money on Maravai LifeSciences Holdings, Inc.(MRVI) should contact Levi & ... - Bluefield Daily Telegraph
MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming DeadlinesMRVI | FinancialContent - FinancialContent
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - Business Wire
DEADLINE ALERT for SWKS, MRVI, APP, and RC: The Law Offices - GlobeNewswire
MRVI DEADLINE TODAY: Maravai LifeSciences (MRVI) Investors - GlobeNewswire
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com
MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsMRVI - GuruFocus
The Gross Law Firm Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMRVI - PR Newswire
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI)May 5, 2025 Deadline to JoinContact Levi & Korsinsky - Longview News-Journal
Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action – Hagens Berman - GlobeNewswire
Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit - Bluefield Daily Telegraph
Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - marketscreener.com
MRVI Shares Experience Decline in Value - knoxdaily.com
The Gross Law Firm Notifies Shareholders of Maravai LifeSciences Holdings, Inc.(MRVI) of a - Bluefield Daily Telegraph
Holzer & Holzer, LLC Reminds Investors of the May 5, 2025 - GlobeNewswire
Balance Sheet Insights: Maravai LifeSciences Holdings Inc (MRVI)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Maravai LifeSciences to Announce Q1 2025 Financial Results and Host Conference Call on May 12, 2025 - Nasdaq
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025 - GlobeNewswire
Life Sciences Leader Maravai Sets Q1 2025 Earnings Report DateKey Details for Investors - Stock Titan
Lost Money on Maravai LifeSciences Holdings, Inc.(MRVI)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - PR Newswire
MRVI Deadline: MRVI Investors with Losses in Excess of $100K Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit - marketscreener.com
MRVI DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages - GlobeNewswire
MRVI DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. - Bluefield Daily Telegraph
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Levi & Korsinsky Notifies Maravai LifeSciences Holdings, - GlobeNewswire
Prepare Yourself for Liftoff: Maravai LifeSciences Holdings Inc (MRVI) - Sete News
MRVI Investors Have the Opportunity to Lead the Maravai - GlobeNewswire
Lowey Dannenberg Notifies Maravai LifeSciences Holdings, - GlobeNewswire
Maravai LifeSciences Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your RightsMRVI - Morningstar
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Maravai LifeSciences Holdings, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 5, 2025 Deadline to file Lead Plaintiff Motion. - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming DeadlinesMRVI - PR Newswire
May 5, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRVI - Bluefield Daily Telegraph
A closer look at Bit Origin Ltd (BTOG) is warranted - uspostnews.com
Maravai LifeSciences Holdings Inc (MRVI) did well last session? - uspostnews.com
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Shares Are Down -62.48% Year To Date. - Marketing Sentinel
Maravai LifeSciences Holdings Inc [MRVI] Investment Appeal on the Rise - knoxdaily.com
Investors who lost money on Maravai LifeSciences Holdings, Inc.(MRVI) should contact The Gross Law Firm about pending Class ActionMRVI - PR Newswire
MRVI IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences - Bluefield Daily Telegraph
MRVI IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR - GlobeNewswire
מועד אחרון חשוב לתביעה נגד MRVI: רוזן, יועץ למשקיעים מוכר, מעודד את משקיעי Maravai Lifesciences Holdings, Inc להבטיח ייעוץ לפני המועד האחרון החשוב של 5 במאי בתביעה ייצוגית בניירות ערך - GlobeNewswire Inc.
MRVI Deadline: Rosen Law Firm Urges Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
2025-04-27 | Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025MRVI | NDAQ:MRVI | Press Release - Stockhouse
2025-04-27 | MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Class Action LawsuitContact Bronstein, Gewirtz and Grossman, LLC Today! | NDAQ:MRVI | Press Release - Stockhouse
2025-04-26 | Lost Money on Maravai LifeSciences Holdings, Inc.(MRVI)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky | NDAQ:MRVI | Press Release - Stockhouse
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - GlobeNewswire
마라바이 라이프 (MRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):